Delcath Systems Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Delcath Systems Stock Summary

Delcath Systems competes with Neuropace, SurModics, CVRx, LivaNova PLC, and Electromed. Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Delcath Systems operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people.

Delcath Systems Key Financial Ratios

Delcath Systems Key Balance Sheet Accounts

Delcath Systems Key Income Statement Accounts

Delcath Systems Key Cash Accounts

Delcath Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Delcath Systems's current stock value. Our valuation model uses many indicators to compare Delcath Systems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Delcath Systems competition to find correlations between indicators driving Delcath Systems's intrinsic value. More Info.Delcath Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Delcath Systems' Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Delcath Systems' earnings, one of the primary drivers of an investment's value.

Delcath Systems Systematic Risk

Today, most investors in Delcath Systems Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Delcath Systems' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Delcath Systems growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Delcath Systems help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Delcath Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Delcath Systems based on widely used predictive technical indicators. In general, we focus on analyzing Delcath Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Delcath Systems's daily price indicators and compare them against related drivers.

When running Delcath Systems' price analysis, check to measure Delcath Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delcath Systems is operating at the current time. Most of Delcath Systems' value examination focuses on studying past and present price action to predict the probability of Delcath Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delcath Systems' price. Additionally, you may evaluate how the addition of Delcath Systems to your portfolios can decrease your overall portfolio volatility.